Transdermal Drug Delivery Systems Flashcards
Transdermal Drug Delivery Systems (TDDS)
Facilitate the passage of therapeutic quantities of drug substances through the skin and into the general circulation for their systemic effects
Transdermal Drug Delivery
API should migrate through the skin to the underlying blood supply without building up in the dermal layers
Topical Drug Delivery
API should reside in the skin, which is the target organ
Stratum Corneum
10- to 15-µm-thick layer of flat, partially desiccated nonliving tissue
Composition of stratum corneum
~40% protein
~40% water
~20% lipid
Lipid content
1) is concentrated in the extracellular phase of the stratum corneum and largely forms the membrane surrounding the cells
2) Because a major route of drug penetration is through the intercellular channels, the lipid component is considered an important determinant in the first step of absorption
When does drug becomes available for absorption into the general circulation
when it reaches the vascularized dermal layer
Advantages of TDDS
1) Bypass hepatic “first-pass” and gastrointestinal incompatibility
2) Reduce side effects due to the optimization of the blood concentration-time profile
3) Provide predictable and extended duration of activity
4) Greater patient compliance due to the elimination of multiple dosing schedules
5) Reversibility of drug delivery
Disadvantages of TDDS
1) Only relatively potent drugs are suitable candidates
2) Contact dermatitis
TDDS shelf life
up to 2 years
TDDS patch size
< 40 cm2
TDDS dose frequency
once a day to once a week
TDDS aesthetic appeal
clear, tan, or white color
TDDS packaging
Easy removal of release liner and minimum number of steps required to apply
TDDS skin adhesion
Does not fall-off during dosing
TDDS skin reactions
Nonirritating and nonsensitizing
TDDS Drug release
Consistent pharmacokinetic and pharmacodynamic profiles over time
Factors Affecting Percutaneous Absorption ( listen to lec cap)
1) Drug concentration
2) Area of application
3) Lipophilic:Hydrophilic solubilities
4) Molecular weight
5) Skin hydration, needs to be dry
6) Skin thickness
7) Exposure time
Percutaneous Absorption Enhancers: Chemical enhancers
1) increase skin permeability by reversibly damaging or altering the physicochemical nature of the stratum corneum to reduce its diffusional resistance
2) Increased hydration of the stratum corneum
and/or
3) A change in the structure of the lipids and lipoproteins in the intercellular channels through solvent action or denaturation
Percutaneous Absorption Enhancers chemical enhancers’ selection is based on?
efficacy, low dermal toxicity and compatibility with other components
chemical enhancers example
Acetone Azone Dimethyl sulfoxide (DMSO) Ethanol Oleic acid Polyethylene glycol Propylene glycol Sodium lauryl sulfate
Iontophoresis
delivery of a charged chemical compound across the skin membrane using an electrical field
Sonophoresis
high frequency ultrasound to enhance transdermal drug delivery
Monolithic systems
1) incorporate a drug matrix layer between backing and frontal layers
2) Drug is dispersed in a matrix layer composed of a polymeric material which controls the rate of drug release